Synapse - Mark Kris

Results (223)

Incidence of EGFR Exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas

Journal Article

D'Angelo, S. P.; Pietanza, M. C.; Johnson, M. L.; Riely, G. J.; Miller, V. A.; Sima, C. S.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Rebiopsy of lung cancer patients with acquired resistance to EGFR inhibitors and enhanced detection of the T790M mutation using a locked nucleic acid-based assay

Journal Article

Arcila, M. E.; Oxnard, G. R.; Nafa, K.; Riely, G. J.; Solomon, S. B.; Zakowski, M. F.; Kris, M. G.; Pao, W.; Miller, V. A.; Ladanyi, M.
Clinical Cancer Research (2011)

Fulltext@MSK | Save

Frequency of EGFR and KRAS mutations in lung adenocarcinomas in african americans

Journal Article

Reinersman, J. M.; Johnson, M. L.; Riely, G. J.; Chitale, D. A.; Nicastri, A. D.; Soff, G. A.; Schwartz, A. G.; Sima, C. S.; Ayalew, G.; Lau, C.; more...
Journal of Thoracic Oncology (2011)

Fulltext@MSK | Save

Reflex testing of resected stage i through III lung adenocarcinomas for EGFR and KRAS mutation: Report on initial experience and clinical utility at a single center

Journal Article

D'Angelo, S. P.; Park, B.; Azzoli, C. G.; Kris, M. G.; Rusch, V.; Ladanyi, M.; Zakowski, M. F.
Journal of Thoracic and Cardiovascular Surgery (2011)

Fulltext@MSK | Save

Clinical course of patients (pts) with acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKI)

Meeting Abstract

Oxnard, G. R.; Riely, G. J.; Arcila, M. H.; Kris, M. G.; Pao, W.; Ladanyi, M.; Miller, V. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

EGFR mutations in men and cigarette smokers with lung adenocarcinoma

Meeting Abstract

Pietanza, M.; D'Angelo, S. P.; Johnson, M. L.; Paik, P. K.; Riely, G. J.; Miller, V. A.; Zakowski, M. F.; Rusch, V. W.; Ladanyi, M.; Kris, M. G.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Initial results of LC-MAP: An institutional program to routinely profile tumor specimens for the presence of mutations in targetable pathways in all patients with lung adenocarcinoma

Meeting Abstract

Kris, M. G.; Lau, C. Y.; Ang, D.; Brzostowski, E.; Riely, G. J.; Rusch, V. W.; Jhanwar, S.; Lash, A.; Zakowski, M. F.; Ladanyi, M.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Association of KRAS and EGFR mutations with survival in patients with advanced lung adenocarcinoma

Meeting Abstract

Johnson, M. L.; Sima, C.; Paik, P. K.; Janjigian, Y. Y.; Pao, W.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

A pilot study of volume measurement as a method of tumor response evaluation to aid biomarker development

Journal Article

Zhao, B.; Oxnard, G. R.; Moskowitz, C. S.; Kris, M. G.; Pao, W.; Guo, P.; Rusch, V.; Ladanyi, M.; Rizvi, N. A.; Schwartz, L. H.
Clinical Cancer Research (2010)

Fulltext@MSK | Save

Core needle lung biopsy specimens: Adequacy for EGFR and KRAS mutational analysis

Journal Article

Solomon, S. B.; Zakowski, M. F.; Pao, W.; Thornton, R. H.; Ladanyi, M.; Kris, M. G.; Rusch, V. W.; Rizvi, N. A.
American Journal of Roentgenology (2010)

Fulltext@MSK | Save